Sigilon Therapeutics Inc Stock, NASDAQ:SGTX
100 Binney Street, Suite 600, Cambridge, Massachusetts 02142
United States of America
Number of Employees:
Sigilon Therapeutics, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutic treatments for a wide range of chronic diseases. Its program includes Rare Blood Disorders; Lysosomal Storage Diseases; and Endocrine and Other Chronic Diseases. The company was founded by Daniel G. Anderson, Robert S. Langer Jr., Jose Oberholzer, Arturo Vegas, and Omid Veiseh on May 14, 2015 and is headquartered in Cambridge, MA.